Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial.
Lancet. 2022 Aug 27;400(10353):680-690. doi: 10.1016/S0140-6736(22)01472-6. Epub 2022 Aug 22.
Lancet. 2022.
PMID: 36007534
Free PMC article.
Clinical Trial.
Who really benefits from drug combinations and long titrations for pain? - Authors' reply.
Tesfaye S, Sloan G, White D, Bradburn M, Bouhassira D, Selvarajah D; OPTION-DM trial group.
Tesfaye S, et al.
Lancet. 2023 Jan 21;401(10372):192-193. doi: 10.1016/S0140-6736(23)00057-0.
Lancet. 2023.
PMID: 36681412
Free article.
No abstract available.
Item in Clipboard
Cite
Cite